SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-20-007874
Filing Date
2020-11-10
Accepted
2020-11-10 17:00:30
Documents
61
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_111020p.htm 10-Q 498125
2 EXHIBIT 31.1 exh_311.htm EX-31.1 9492
3 EXHIBIT 31.2 exh_312.htm EX-31.2 9625
4 EXHIBIT 32.1 exh_321.htm EX-32.1 3327
5 EXHIBIT 32.2 exh_322.htm EX-32.2 3188
12 GRAPHIC logo.jpg GRAPHIC 13002
  Complete submission text file 0001171843-20-007874.txt   3190414

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE apto-20200930.xml EX-101.INS 587150
7 XBRL SCHEMA FILE apto-20200930.xsd EX-101.SCH 43234
8 XBRL CALCULATION FILE apto-20200930_cal.xml EX-101.CAL 30937
9 XBRL DEFINITION FILE apto-20200930_def.xml EX-101.DEF 256507
10 XBRL LABEL FILE apto-20200930_lab.xml EX-101.LAB 230771
11 XBRL PRESENTATION FILE apto-20200930_pre.xml EX-101.PRE 282705
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32001 | Film No.: 201301958
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences